Technical Analysis for CBMG - Cellular Biomedicine Group, Inc.

Grade Last Price % Change Price Change
grade F 18.01 3.74% 0.65
CBMG closed up 3.74 percent on Tuesday, March 19, 2019, on approximately normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical CBMG trend table...

Date Alert Name Type % Chg
Mar 19 Oversold Stochastic Weakness 0.00%
Mar 18 Jack-in-the-Box Bearish Bearish Swing Setup 3.74%
Mar 18 Bullish Engulfing Bullish 3.74%
Mar 18 Lower Bollinger Band Walk Weakness 3.74%
Mar 18 Lower Bollinger Band Touch Weakness 3.74%
Mar 18 Oversold Stochastic Weakness 3.74%
Mar 15 MACD Bearish Centerline Cross Bearish 12.21%
Mar 15 Expansion Breakdown Bearish Swing Setup 12.21%
Mar 15 Expansion Pivot Sell Setup Bearish Swing Setup 12.21%
Mar 15 Volume Surge Other 12.21%

Older signals for CBMG ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Cellular Biomedicine Group Inc., a biomedicine company, engages in the development of treatments for cancerous and degenerative diseases in Greater China. The company focuses on developing and marketing cell-based therapeutic products to treat serious chronic and degenerative diseases, including cancer, osteoarthritis, tissue damage, spinal muscular atrophy, various inflammatory diseases, and joint diseases. It is developing treatments utilizing proprietary cell technologies, which include tumor cell specific dendritic cells for the treatment of a range of cancers; human adipose-derived mesenchymal progenitor cells for the treatment of joint disease; human umbilical cord-derived mesenchymal progenitor cells; human embryo-derived motor neuron progenitor precursor cells; and human embryo-derived neuronal progenitor precursor cells for the treatment of central nervous system diseases. The company is headquartered in Palo Alto, California.
Cancer Life Sciences Biology Cancers Stem Cells Tumor Osteoarthritis Inflammatory Diseases Spinal Muscular Atrophy Stem Cell Therapy Central Nervous System Diseases Degenerative Disease Treatment Of Central Nervous System Diseases Mesenchymal Stem Cell Treatment Of A Range Of Cancers
Is CBMG a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 25.0
52 Week Low 12.04
Average Volume 48,322
200-Day Moving Average 18.5919
50-Day Moving Average 18.278
20-Day Moving Average 18.3205
10-Day Moving Average 18.181
Average True Range 0.9798
ADX 13.57
+DI 21.3401
-DI 29.3019
Chandelier Exit (Long, 3 ATRs ) 17.2906
Chandelier Exit (Short, 3 ATRs ) 18.8394
Upper Bollinger Band 20.1728
Lower Bollinger Band 16.4682
Percent B (%b) 0.42
BandWidth 20.221064
MACD Line -0.2121
MACD Signal Line -0.0124
MACD Histogram -0.1997
Fundamentals Value
Market Cap 254.09 Million
Num Shares 14.1 Million
EPS -2.06
Price-to-Earnings (P/E) Ratio -8.74
Price-to-Sales 587.89
Price-to-Book 2.44
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 19.68
Resistance 3 (R3) 19.56 18.88 19.40
Resistance 2 (R2) 18.88 18.46 18.94 19.30
Resistance 1 (R1) 18.45 18.20 18.67 18.57 19.21
Pivot Point 17.77 17.77 17.88 17.83 17.77
Support 1 (S1) 17.34 17.35 17.56 17.46 16.81
Support 2 (S2) 16.66 17.09 16.72 16.72
Support 3 (S3) 16.23 16.66 16.62
Support 4 (S4) 16.35